相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Effect of Natural Health Products and Traditional Medicines on the Activity of Human Hepatic Microsomal-Mediated Metabolism of Oseltamivir
Rui Liu et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2016)
Understanding and managing the adverse effects of antiretroviral therapy
Trevor Hawkins
ANTIVIRAL RESEARCH (2010)
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Catia Marzolini et al.
ANTIVIRAL THERAPY (2010)
In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations
Giulio Vistoli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin
M. J. Hatfield et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Loss of TGH/Ces3 in Mice Decreases Blood Lipids, Improves Glucose Tolerance, and Increases Energy Expenditure
Enhui Wei et al.
CELL METABOLISM (2010)
Recognition and Management of Significant Drug Interactions in HIV Patients: Challenges in Using Available Data to Guide Therapy
A. K. Pau et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Antiretroviral Treatment of Adult HIV Infection 2010 Recommendations of the International AIDS Society-USA Panel
Melanie A. Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Antiretroviral therapy and management of HIV infection
Paul A. Volberding et al.
LANCET (2010)
Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: Potential sources of metabolic drug interactions
Hao-Jie Zhu et al.
TOXICOLOGY (2010)
The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters
Olena Kis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Activation of the Antiviral Prodrug Oseltamivir Is Impaired by Two Newly Identified Carboxylesterase 1 Variants
Hao-Jie Zhu et al.
DRUG METABOLISM AND DISPOSITION (2009)
Different Inhibitory Effects in Rat and Human Carboxylesterases
Shiori Takahashi et al.
DRUG METABOLISM AND DISPOSITION (2009)
Age- and Sex-Related Expression and Activity of Carboxylesterase 1 and 2 in Mouse and Human Liver
Hao-Jie Zhu et al.
DRUG METABOLISM AND DISPOSITION (2009)
The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America
Scott W. Grimm et al.
DRUG METABOLISM AND DISPOSITION (2009)
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: Clinical significance and molecular basis
Hao-Jie Zhu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients
Deborah Hirt et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine
Teruko Imai et al.
DRUG METABOLISM AND DISPOSITION (2006)
Structural insights into drug processing by human carboxylesterase 1: Tamoxifen, mevastatin, and inhibition by benzil
CD Fleming et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme
S Bencharit et al.
NATURE STRUCTURAL BIOLOGY (2003)
Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death
CB Hare et al.
CLINICAL INFECTIOUS DISEASES (2002)
Current progress on esterases: From molecular structure to function
T Satoh et al.
DRUG METABOLISM AND DISPOSITION (2002)
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047
CJ Fichtenbaum et al.
AIDS (2002)
Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin
PH Hsyu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
